The class of chemicals that can be considered as indirect activators of Plexin-B2 primarily includes inhibitors of various kinases and enzymes involved in key signaling pathways. These chemicals modulate the activity of pathways such as Rho/ROCK, MAPK/ERK, PI3K/Akt, and others, which are intricately connected to Plexin-B2 function. The modulation of these pathways can lead to changes in the activity of Plexin-B2, especially in the context of its role in neural development, angiogenesis, and cancer biology.
These activators are diverse in their structure and function, with some being more specific to certain kinases (like Y-27632 for ROCK and U0126 for MEK1/2), while others have broader effects on multiple pathways (like Rapamycin and Wortmannin). The use of these chemicals can help in dissecting the complex signaling networks associated with Plexin-B2 and can provide insights into how altering these pathways can impact Plexin-B2 mediated processes. Additionally, their utility extends beyond the scope of Plexin-B2, as they are widely used in research to study various aspects of cellular signaling and physiology. It's important to note that while these chemicals can indirectly influence Plexin-B2 activity, their effects are mediated through complex and sometimes overlapping signaling cascades.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
A specific inhibitor of MEK, which indirectly influences Plexin-B2 by modulating the MAPK/ERK pathway. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor that can affect multiple signaling pathways, including those associated with Plexin-B2 signaling. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
A PI3K inhibitor that can indirectly modulate Plexin-B2 activity through the PI3K/Akt pathway. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
An inhibitor of JNK, part of the MAPK pathway, potentially influencing Plexin-B2 activity. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Activates adenylate cyclase, leading to an increase in cAMP, which can indirectly influence Plexin-B2 through cAMP-dependent pathways. | ||||||
2-Methoxyestradiol | 362-07-2 | sc-201371 sc-201371A | 10 mg 50 mg | $71.00 $288.00 | 6 | |
A metabolite of estradiol that can modulate multiple signaling pathways potentially influencing Plexin-B2. | ||||||
Casein Kinase I Inhibitor, D4476 | 301836-43-1 | sc-202522 | 1 mg | $99.00 | 6 | |
A casein kinase 1 inhibitor, potentially affecting pathways associated with Plexin-B2. | ||||||